Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “XELOX”

191 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 191 results

Testing effectiveness (Phase 2)UnknownNCT00363831
What this trial is testing

Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Neoplasms
The University of Hong Kong 42
Large-scale testing (Phase 3)UnknownNCT03355612
What this trial is testing

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

Who this might be right for
Gastric Carcinoma
Tianjin Medical University Cancer Institute and Hospital 456
Testing effectiveness (Phase 2)Study completedNCT03929666
What this trial is testing

A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer

Who this might be right for
HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer
Jazz Pharmaceuticals 74
Large-scale testing (Phase 3)Looking for participantsNCT06346197
What this trial is testing

Combination of Immune Checkpoint in Locally Advanced or Metastatic MSI/dMMR Esogastric Adenocarcinomas

Who this might be right for
Gastric CancerMSI-HMetastatic Cancer+1 more
Centre Leon Berard 132
Testing effectiveness (Phase 2)UnknownNCT03038256
What this trial is testing

Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial

Who this might be right for
Rectal CancerPathological Complete ResponseDisease Free Survival
Peking University People's Hospital 244
Testing effectiveness (Phase 2)UnknownNCT04659382
What this trial is testing

Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atezolizumab (Immune Chekpoint Inhibitor) in Patients With Liver-dominant Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerpMMRMSS+2 more
Federation Francophone de Cancerologie Digestive 52
Testing effectiveness (Phase 2)Study completedNCT02015169
What this trial is testing

Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis

Who this might be right for
HER2-positive Gastric Cancer Patients With Liver Metastasis
Samsung Medical Center 32
Testing effectiveness (Phase 2)Ended earlyNCT00950820
What this trial is testing

Study to Evaluate the Effects of Panitumumab if Combined With Chemotherapy for 2nd Treatment of Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
AIO-Studien-gGmbH 9
Large-scale testing (Phase 3)Study completedNCT00202774
What this trial is testing

Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 348
Testing effectiveness (Phase 2)UnknownNCT04324476
What this trial is testing

Bevacizumab Plus XELOX/XELIRI for First-line Treatment in Unresectable Advanced Colorectal Cancer

Who this might be right for
Advanced Colorectal Cancer
Jiangsu Cancer Institute & Hospital 50
Large-scale testing (Phase 3)Study completedNCT00399035
What this trial is testing

Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
AstraZeneca 1,254
Large-scale testing (Phase 3)UnknownNCT03389659
What this trial is testing

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Who this might be right for
Vitamin D3
Tianjin Medical University Cancer Institute and Hospital 750
Testing effectiveness (Phase 2)Ended earlyNCT01955629
What this trial is testing

Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer Patient

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 4
Testing effectiveness (Phase 2)UnknownNCT05970302
What this trial is testing

XELOX +Bev +Tislelizumab for First-line Treatment of MSS/pMMR RAS-mutated mCRC

Who this might be right for
TislelizumabBevacizumabOxaliplatin+5 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 52
Testing effectiveness (Phase 2)UnknownNCT03792269
What this trial is testing

Intraperitoneal and System Chemotherapy Versus XELOX as First-line Chemotherapy for mCRC

Who this might be right for
Colorectal Cancer MetastaticChemotherapy EffectChemotherapeutic Toxicity
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Testing effectiveness (Phase 2)UnknownNCT00985556
What this trial is testing

Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer
Yonsei University 130
Testing effectiveness (Phase 2)WithdrawnNCT02079220
What this trial is testing

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
James J Lee
Testing effectiveness (Phase 2)UnknownNCT06383559
What this trial is testing

Safety and Efficacy of XELOX Combined With Sintilimab and Lenvatinib in Advanced AFP-positive Gastric Cancer Patients

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848
What this trial is testing

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Adenocarcinoma
Chongqing University Cancer Hospital 20
Next Page